SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update
November 13, 2024 17:05 ET
|
SeaStar Medical Holding Corporation
DENVER, Nov. 13, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a commercial-stage medical device company developing proprietary...
Safety Shot Reports Transformative Third Quarter 2024: Rebranding, Strategic Partnerships, and Expanded Distribution Drive Growth
November 13, 2024 08:30 ET
|
Safety Shot, Inc.
Jupiter, FL, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (The “Company” or “Safety Shot”), a leading innovator in the functional beverage industry, today announced key...
Cocrystal Pharma Reports Third Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
November 13, 2024 08:00 ET
|
Cocrystal Pharma, Inc.
BOTHELL, Wash., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three and nine months ended September 30,...
Giftify, Inc. Reports Third Quarter 2024 Financial Results, Reports Revenue Growth of 14.9% to $23.2 Million
November 13, 2024 08:00 ET
|
Giftify, Inc.
Company forecasts at least $85 million in revenue for 2024 Guidance reflects the Company's strong market position in the growing secondary gift card market, estimated to reach $2.1 billion by 2025 ...
Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights
November 12, 2024 17:00 ET
|
Serina Therapeutics, Inc.
HUNTSVILLE, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company advancing its lead IND candidate SER-252 for advanced...
Bright Mountain Media, Inc Announces Third Quarter 2024 Financial Results
November 12, 2024 17:00 ET
|
Bright Mountain Media, Inc.
Third quarter revenue decreased to $14.2 million compared to $15.3 million for the third quarter of 2023.Year to date revenue increased by $10.2 million to $39.6 million compared to $29.4 million for...
BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update
November 12, 2024 16:05 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Nov. 12, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem...
Palisade Bio Reports Third Quarter 2024 Financial Results and Outlines Key Accomplishments and Next Steps to Advance Lead Program PALI-2108
November 12, 2024 08:45 ET
|
Palisade Bio, Inc.
Commenced enrollment and dosing in Phase 1 clinical study of PALI-2108 for the treatment of moderate-to-severe Ulcerative Colitis (UC) Carlsbad, CA, Nov. 12, 2024 (GLOBE NEWSWIRE) --...
ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024
November 11, 2024 09:52 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 11, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and diagnostics company, today announced that...
Vislink to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024, at 8:30 a.m. ET
November 08, 2024 08:10 ET
|
Vislink Technologies, Inc.
Mt. Olive, NJ, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (Nasdaq: VISL), a global technology leader in the capture, delivery, and management of...